Can cost efficiencies and homecare solve European healthcare problems?
This article was originally published in SRA
Executive Summary
We’re all familiar with the pressures piling up on healthcare systems around the world. People are living longer and diseases of ageing, such as dementia, are becoming more prevalent. Some illnesses linked to lifestyle, such as diabetes, are also on the rise.
You may also be interested in...
France Rejects Advice To Delay Second Dose Of Pfizer Vaccine
The French government has decided not to extend the recommended interval between the two doses of the Pfizer/BioNTech coronavirus vaccine.
French HTA Body Backs Routine Six-Week Interval In COVID-19 Vaccine Dosing
France's health technology assessment body says that delaying by six weeks the second dose of the two mRNA vaccines approved for use against COVID-19 would allow at least 700,000 more people to receive their jab in the first month.
Coronavirus Notebook: EU Publishes CureVac Vaccine Contract, AZ and Pfizer Under Attack Over Supply Cuts
The European Ombudsman has opened an inquiry regarding the disclosure of vaccine contracts with other companies, and the European Commission is planning a “sharing mechanism” for vaccines bought by EU member states.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: